Health Sciences

Gene therapy for congenital blindness has taken another step forward, as researchers further improved vision in three adult patients previously treated in one eye. After receiving the same treatment in their other eye, the patients became better able to see in dim light, and two were able to navigate obstacles in low-light situations. No adverse effects occurred.

The molecular pathway that carries time-of-day signals from the body's internal clock to ultimately guide daily behavior is like a black box, says Amita Sehgal, PhD, the John Herr Musser Professor of Neuroscience and Co-Director, Comprehensive Neuroscience Center, at the

PHILADELPHIA  – A recent study by researchers from the University of Pennsylvania and the University of Maryland identified the reasons why college-age individuals would be tested for sexually transmitted diseases.  These findings are valuable in developing public health awareness advertising campaigns.        

PHILADELPHIA -- Members of a University of Pennsylvania research team have shown that they can prevent, or even reverse, a blinding retinal disease, X-linked Retinitis Pigmentosa, or XLRP, in dogs.

People who suffer from sleep disturbances are at major risk for obesity, diabetes, and coronary artery disease, according to new research from the Perelman School of Medicine at the University of Pennsylvania.

PHILADELPHIA --  Over many generations, people living in the high-altitude regions of the Andes or on the Tibetan Plateau have adapted to life in low-oxygen conditions.

Research conducted by a Penn scholar was named one of 2011’s “Top 10 New Findings in Parenting” by TIME magazine.

PHILADELPHIA — More than 17 million Americans 65 or older have at least one firearm.  Based on the current patterns of gun ownership and population growth, the number of elderly people who own a firearm is expected to increase.  In an article released by the American Journal of Public Health, Susan B.

The Perelman School of Medicine at the University of Pennsylvania is one of six institutions to be named part of the National Heart, Lung, and Blood Institute’s Lung Repair and Regeneration Consortium (LRRC). Each of the institutions will receive $2.5 million over five years.